Are you a member yet?

Register
Login

Why should I become a member?

Serum Industry

About Us

HISTORY

The International Serum Industry Association was formed in June 2006 with a specific focus on the Serum Industry. Since that time the scope of the Association has broadened to include all animal derived products for use in the multibillion dollar life science and biomedical sectors.

The Association does not include food applications or human derived materials within its sphere of influence.

ISIA MISSION

ETHICS

ISIA shall establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal derived products supply industry.

SAFETY AND SAFE USE

Our primary focus will be on safety and safe use of serum and animal derived products through proper origin traceability, and truth in labeling, and appropriate standardization and oversight.

EDUCATION

We will also work to educate stakeholders on the scientific foundation of the safe use of serum and animal derived products.

PLANNING FOR OUR FUTURE

 

ISIA has begun an extensive Strategic Planning Initiative focused on five key areas.

Harmonization/ Standardization

ISIA is working to harmonize technical standards, testing methods, and import/export for the industry.

Marketing

ISIA is working to proactively educate those involved with our products about our industry, and our Association.

Membership

ISIA is working to broaden its membership to be able to better represent the industry.

Regulatory

ISIA is working to interpret regulations, participate in the development of new regulations affecting our industry, and strengthen our position as resource and liason with global regulatory agencies.

Traceability

ISIA is working to continually improve, promote, and manage the ISIA Traceability Program. Additionally, ISIA is working to strengthen the Traceability Program in the future by researching the applicability of quantitative methods and new technologies in the Serum industry.

GLOBAL NETWORK

ISIA has developed a worldwide network of contacts with regulatory agencies, other associations and interested parties. We continue to proactively develop this resource for our membership. 

Below see a schematic of the ISIA global contacts.

BOARD OF DIRECTORS

Jenny Murray Chairman LPS
Randy Fitzgerald Vice-Chairman Proliant Biologicals
Stephen Judd Director Axenia BioLogix
Brian Lewis Director VWR/Seradigm
Elizabeth Meixner
Director Moregate Biotech
Rick Mulford Director Vacca Biologics
Nicole Green Director Central Biomedia
Jeff Pease Director RMBio
Cody Yarborough
Director Bovalco
Skip Wrape
Director
River City Biologicals
Simon Egan Director BioArra
Bob Curry Director GE Healthcare

Officers

Name Position Company
Rosemary Versteegen
CEO*
ISIA
Stephen Judd
CFO*
Axenia BioLogix
Jock Elliott Secretary* Moregate Biotech
*Non-voting positions